Exploring Xiaojianzhong decoction's potential in gastric cancer treatment: Integrative insights and experimental validation

Chun-Han Cheng,Wen-Rui Hao,Tzu-Hurng Cheng
DOI: https://doi.org/10.4251/wjgo.v16.i12.4553
2024-11-09
World Journal of Gastrointestinal Oncology
Abstract:Gastric cancer (GC) remains a formidable global health concern with significant morbidity and mortality rates, despite the fact that numerous advances have been made to improve conventional therapies. Xiaojianzhong decoction (XJZ), a traditional Chinese medicine, has garnered academic attention as a multicomponent, multitarget approach to managing GC. The present editorial explores the potential of XJZ in the treatment of GC through a comprehensive analysis of network pharmacology and experimental validation. Network pharmacology was used to identify key molecular targets of XJZ, including interleukin 6, prostaglandin-endoperoxide synthase 2, and matrix metalloproteinase 9, and in vitro experiments were used to confirm the efficacy of XJZ in inhibiting cell proliferation, inducing apoptosis, and modulating gene expression associated with GC progression. This editorial highlights XJZ as a promising therapeutic strategy for GC and indicates a need for further clinical exploration and validation of its efficacy.
oncology,gastroenterology & hepatology
What problem does this paper attempt to address?